Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation

Journal of Immunology

Volumn 185, Issue 5, 2010, Pages 3076-3085

  Naura, Amarjit S ^a   Zerfaoui, Mourad ^a   Kim, Hogyoung ^a   Abd Elmageed, Zakaria Y ^a   Rodriguez, Paulo C ^a   Hans, Chetan P ^a   Ju, Jihang ^a   Errami, Youssef ^a   Park, Jiwon ^a   Ochoa, Augusto C ^a   Hamid Boulares, A ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ARGINASE; GELATINASE A; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OVALBUMIN; PEROXYNITRITE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; NOS2 PROTEIN, MOUSE;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DAMAGE; ENZYME ACTIVATION; EOSINOPHILIA; FIBROBLAST; GENE DELETION; INFLAMMATION; INFLAMMATORY CELL; LUNG ALVEOLUS CELL; LUNG FIBROSIS; MOUSE; MUCUS SECRETION; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TISSUE INJURY; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHICKEN; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; MUCUS; PATHOLOGY; PHYSIOLOGY; SECRETION;

ACUTE DISEASE; ALLERGENS; ANIMALS; CELLS, CULTURED; CHICKENS; EOSINOPHILIA; GENE DELETION; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-13; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCUS; NITRIC OXIDE SYNTHASE TYPE II; OVALBUMIN; PULMONARY FIBROSIS;

EID: 78049413973     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904214     Document Type: Article

References (58)

1. Taylor, D. R., E. D. Bateman, L. P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, J. C. de Jongste, et al. 2008. A new perspective on concepts of asthma severity and control. Eur. Respir. J. 32: 545-554.
2. DeNicola, L. R., N. Kissoon, L. J. Duckworth, K. V. Blake, S. P. Murphy, and P. E. Silkoff. 2000. Exhaled nitric oxide as an indicator of severity of asthmatic inflammation. Pediatr. Emerg. Care 16: 290-295.
3. Ricciardolo, F. L., F. P. Nijkamp, and G. Folkerts. 2006. Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Curr. Drug Targets 7: 721-735.
4. Kirkham, P., and I. Rahman. 2006. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol. Ther. 111: 476-494.
5. MacNee, W. 2001. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol. 429: 195-207.
6. Beckman, J. S. 2009. Understanding peroxynitrite biochemistry and its potential for treating human diseases. Arch. Biochem. Biophys. 484: 114-116.
7. Hogg, J. C. 1997. The pathology of asthma. APMIS 105: 735-745.
8. Bratt, J. M., L. M. Franzi, A. L. Linderholm, M. S. Last, N. J. Kenyon, and J. A. Last. 2009. Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol. Appl. Pharmacol. 234: 273-280.
9. Ckless, K., A. Lampert, J. Reiss, D. Kasahara, M. E. Poynter, C. G. Irvin, L. K. Lundblad, R. Norton, A. van der Vliet, and Y. M. Janssen-Heininger. 2008. Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J. Immunol. 181: 4255-4264.
10. Maarsingh, H., A. B. Zuidhof, I. S. Bos, M. van Duin, J. L. Boucher, J. Zaagsma, and H. Meurs. 2008. Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. Am. J. Respir. Crit. Care Med. 178: 565-573.
11. Pesce, J. T., T. R. Ramalingam, M. M. Mentink-Kane, M. S. Wilson, K. C. El Kasmi, A. M. Smith, R. W. Thompson, A. W. Cheever, P. J. Murray, and T. A. Wynn. 2009. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 5: e1000371.
12. Bratt, J. M., L. M. Franzi, A. L. Linderholm, E. M. O'Roark, N. J. Kenyon, and J. A. Last. 2010. Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol. Appl. Pharmacol. 242: 1-8.
13. Mathrani, V. C., N. J. Kenyon, A. Zeki, and J. A. Last. 2007. Mouse models of asthma: can they give us mechanistic insights into the role of nitric oxide? Curr. Med. Chem. 14: 2204-2213.
14. Hansel, T. T., S. A. Kharitonov, L. E. Donnelly, E. M. Erin, M. G. Currie, W. M. Moore, P. T. Manning, D. P. Recker, and P. J. Barnes. 2003. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J. 17: 1298-1300.
15. Mulrennan, S. A., and A. E. Redington. 2004. Nitric oxide synthase inhibition: therapeutic potential in asthma. Treat. Respir. Med. 3: 79-88.
16. Brindicci, C., K. Ito, P. J. Barnes, and S. A. Kharitonov. 2007. Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers. Chest 132: 581-588.
17. Singh, D., D. Richards, R. G. Knowles, S. Schwartz, A. Woodcock, S. Langley, and B. J. O'Connor. 2007. Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am. J. Respir. Crit. Care Med. 176: 988-993.
18. Naura, A. S., C. P. Hans, M. Zerfaoui, D. You, S. A. Cormier, M. Oumouna, and A. H. Boulares. 2008. Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation. Clin. Exp. Allergy 38: 839-846.
19. Boulares, A. H., A. J. Zoltoski, Z. A. Sherif, P. Jolly, D. Massaro, and M. E. Smulson. 2003. Gene knockout or pharmacological inhibition of poly (ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 28: 322-329.
20. Boulares, A. H., A. J. Zoltoski, A. Yakovlev, M. Xu, and M. E. Smulson. 2001. Roles of DNA fragmentation factor and poly(ADP-ribose) polymerase in an amplification phase of tumor necrosis factor-induced apoptosis. J. Biol. Chem. 276: 38185-38192.
21. Naura, A. S., C. P. Hans, M. Zerfaoui, Y. Errami, J. Ju, H. Kim, K. Matrougui, J. G. Kim, and A. H. Boulares. 2009. High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors. Lab. Invest. 89: 1243-1251.
22. Le Saux, C. J., K. Teeters, S. K. Miyasato, P. R. Hoffmann, O. Bollt, V. Douet, R. V. Shohet, D. H. Broide, and E. K. Tam. 2008. Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling. J. Biol. Chem. 283: 5760-5768.
23. Boulares, A. H., A. G. Yakovlev, V. Ivanova, B. A. Stoica, G. Wang, S. Iyer, and M. Smulson. 1999. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 274: 22932-22940.
24. Rodriguez, P. C., D. G. Quiceno, J. Zabaleta, B. Ortiz, A. H. Zea, M. B. Piazuelo, A. Delgado, P. Correa, J. Brayer, E. M. Sotomayor, et al. 2004. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64: 5839-5849.
25. Naura, A. S., R. Datta, C. P. Hans, M. Zerfaoui, B. M. Rezk, Y. Errami, M. Oumouna, K. Matrougui, and A. H. Boulares. 2009. Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia. Eur. Respir. J. 33: 252-262.
26. Rogers, D. F. 2007. Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir. Care 52: 1134-1146, discussion 1146-1149.
27. Barnes, P. J. 2008. The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 118: 3546-3556.
28. Cooper, P. R., and R. A. Panettieri, Jr. 2008. Steroids completely reverse albuterol-induced beta(2)-adrenergic receptor tolerance in human small airways. J. Allergy Clin. Immunol. 122: 734-740.
29. Stetler-Stevenson, W. G. 2008. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci. Signal. 1: re6.
30. Wong, S., M. G. Belvisi, and M. A. Birrell. 2009. MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies. Respir. Res. 10: 72.
31. Hans, C. P., Y. Feng, A. S. Naura, M. Zerfaoui, B. M. Rezk, H. Xia, A. D. Kaye, K. Matrougui, E. Lazartigues, and A. H. Boulares. 2009. Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress. PLoS ONE 4: e7430.
32. Murata, M., and S. Kawanishi. 2004. Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation. Biochem. Biophys. Res. Commun. 316: 123-128.
33. Pinlaor, S., Y. Hiraku, N. Ma, P. Yongvanit, R. Semba, S. Oikawa, M. Murata, B. Sripa, P. Sithithaworn, and S. Kawanishi. 2004. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide 11: 175-183.
34. Pinlaor, S., Y. Hiraku, P. Yongvanit, S. Tada-Oikawa, N. Ma, P. Pinlaor, P. Sithithaworn, B. Sripa, M. Murata, S. Oikawa, and S. Kawanishi. 2006. iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel. Int. J. Cancer 119: 1067-1072.
35. Maarsingh, H., J. Zaagsma, and H. Meurs. 2009. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br. J. Pharmacol. 158: 652-664.
36. Brahmachari, S., and K. Pahan. 2009. Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J. Immunol. 183: 2045-2058.
37. Ray, A., A. Khare, N. Krishnamoorthy, Z. Qi, and P. Ray. 2010. Regulatory T cells in many flavors control asthma. Mucosal Immunol. 3: 216-229.
38. Fernández-Ruiz, V., N. López-Moratalla, and A. González. 2005. Production of nitric oxide and self-nitration of proteins during monocyte differentiation to dendritic cells. J. Physiol. Biochem. 61: 517-525.
39. Kenyon, N. J., K. Gohil, and J. A. Last. 2003. Susceptibility to ovalbumin-induced airway inflammation and fibrosis in inducible nitric oxide synthetase-deficient mice: mechanisms and consequences. Toxicol. Appl. Pharmacol. 191: 2-11.
40. Jain, V. V., K. Kitagaki, T. Businga, I. Hussain, C. George, P. O'shaughnessy, and J. N. Kline. 2002. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J. Allergy Clin. Immunol. 110: 867-872.
41. Simeone-Penney, M. C., M. Severgnini, P. Tu, R. J. Homer, T. J. Mariani, L. Cohn, and A. R. Simon. 2007. Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma. J. Immunol. 178: 6191-6199.
42. Pinelli, V., C. L. Marchica, and M. S. Ludwig. 2009. Allergen-induced asthma in C57Bl/6 mice: hyper-responsiveness, inflammation and remodelling. Respir. Physiol. Neurobiol. 169: 36-43.
43. Pae, S., J. Y. Cho, S. Dayan, M. Miller, A. D. Pemberton, and D. H. Broide. 2010. Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9. Immunogenetics. In press.
44. Homer, R. J., and J. A. Elias. 2005. Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology (Bethesda) 20: 28-35.
45. Wilson, M. S., and T. A. Wynn. 2009. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2: 103-121.
46. Alcorn, J. F., A. S. Guala, J. van der Velden, B. McElhinney, C. G. Irvin, R. J. Davis, and Y. M. Janssen-Heininger. 2008. Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J. Cell Sci. 121: 1036-1045.
47. Zhang, M., Z. Zhang, H. Y. Pan, D. X. Wang, Z. T. Deng, and X. L. Ye. 2009. TGF-beta1 induces human bronchial epithelial cell-to-mesenchymal transition in vitro. Lung 187: 187-194.
48. Heijink, I. H., D. S. Postma, J. A. Noordhoek, M. Broekema, and A. Kapus. 2010. House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 42: 69-79.
49. Hackett, T. L., S. M. Warner, D. Stefanowicz, F. Shaheen, D. V. Pechkovsky, L. A. Murray, R. Argentieri, A. Kicic, S. M. Stick, T. R. Bai, and D. A. Knight. 2009. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am. J. Respir. Crit. Care Med. 180: 122-133.
50. Doerner, A. M., and B. L. Zuraw. 2009. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. Respir. Res. 10: 100.
51. Jung, Y. W., C. L. Zindl, J. F. Lai, C. T. Weaver, and D. D. Chaplin. 2009. MMP induced by Gr-1+ cells are crucial for recruitment of Th cells into the airways. Eur. J. Immunol. 39: 2281-2292.
52. Gu, Z., M. Kaul, B. Yan, S. J. Kridel, J. Cui, A. Strongin, J. W. Smith, R. C. Liddington, and S. A. Lipton. 2002. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186-1190.
53. Bove, P. F., U. V. Wesley, A. K. Greul, M. Hristova, W. R. Dostmann, and A. van der Vliet. 2007. Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am. J. Respir. Cell Mol. Biol. 36: 138-146.
54. Berkman, N., A. Robichaud, R. A. Robbins, G. Roesems, E. B. Haddad, P. J. Barnes, and K. F. Chung. 1996. Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology 89: 363-367.
55. Cuthbertson, B. H., H. F. Galley, and N. R. Webster. 2000. Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury. Crit. Care Med. 28: 1736-1741.
56. Poveda, L., M. Hottiger, N. Boos, and K. Wuertz. 2009. Peroxynitrite induces gene expression in intervertebral disc cells. Spine 34: 1127-1133.
57. Webb, D. C., A. N. McKenzie, A. M. Koskinen, M. Yang, J. Mattes, and P. S. Foster. 2000. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J. Immunol. 165: 108-113.
58. Janssen-Heininger, Y. M., M. E. Poynter, S. W. Aesif, C. Pantano, J. L. Ather, N. L. Reynaert, K. Ckless, V. Anathy, J. van der Velden, C. G. Irvin, and A. van der Vliet. 2009. Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proc. Am. Thorac. Soc. 6: 249-255.